Home
»
Special Topics in Heterocyclic Chemistry, Volume 30
Special Topics in Heterocyclic Chemistry, Volume 30
★★★★★
★★★★★
Regular price
€634.82
A01=Arnold Weissberger
A01=Edward C. Taylor
additional
atom
Author_Arnold Weissberger
Author_Edward C. Taylor
azaderivatives
azaindolizine
bridgehead nitrogen
Category=PNN
chemistry
cyanine
eq_bestseller
eq_isMigrated=1
eq_nobargain
eq_non-fiction
eq_science
fivemembered
hamilton
heterocyclic
heterocyclic compounds
inception
nitrogens
one nitrogen
properties
ring
sixmembered
systems
Product details
- ISBN 9780471672531
- Weight: 454g
- Dimensions: 10 x 10mm
- Publication Date: 27 Jun 2007
- Publisher: John Wiley & Sons Inc
- Publication City/Country: US
- Product Form: Hardback
Delivery/Collection within 10-20 working days
Our Delivery Time Frames Explained
2-4 Working Days: Available in-stock
10-20 Working Days: On Backorder
Will Deliver When Available: On Pre-Order or Reprinting
We ship your order once all items have arrived at our warehouse and are processed. Need those 2-4 day shipping items sooner? Just place a separate order for them!
The Chemistry of Heterocyclic Compounds, since its inception, has been recognized as a cornerstone of heterocyclic chemistry. Each volume attempts to discuss all aspects – properties, synthesis, reactions, physiological and industrial significance – of a specific ring system. To keep the series up-to-date, supplementary volumes covering the recent literature on each individual ring system have been published. Many ring systems (such as pyridines and oxazoles) are treated in distinct books, each consisting of separate volumes or parts dealing with different individual topics. With all authors are recognized authorities, the Chemistry of Heterocyclic Chemistry is considered worldwide as the indispensable resource for organic, bioorganic, and medicinal chemists.
Arnold Weissberger is the author of Special Topics in Heterocyclic Chemistry, Volume 30, published by Wiley.
Edward Curtis Taylor, Jr. was an American chemist who designed and synthesized the chemotherapy drug pemetrexed, an inhibitor of purine biosynthesis, with grant support from the U.S. National Cancer Institute, NIH. Taylor studied for his PhD from 1946 to 1949 at Cornell University with Professor Cornelius Cain.
Qty:
